title: Acute-on-chronic liver failure.
abstract: The Model for End-Stage Liver Disease (MELD) has been the single best predictor of outcome of the progression of cirrhosis. Acute-on-chronic liver failure (ACLF) has been proposed as an alternative path in the natural history of cirrhosis. ACLF occurs in patients with chronic liver disease and is characterized by a precipitating event, resulting in acute deterioration in liver function, multiorgan system failure, and high short-term mortality. In this review, the natural course of patients with ACLF, especially as it relates to management of cirrhotic patients on the transplant waiting list, and its impact on liver transplantation outcomes are defined.
authors.affiliation: Division of Hepatology, Baylor University Medical Center, 3410 Worth Street, Suite 860, Dallas, TX 75246, USA.
authors.forename: Sumeet K
authors.initials: SK
authors.lastname: Asrani
authors.affiliation: Division of Hepatology, Hepatology Research, Annette C. & Harold C. Simmons Transplant Institute, Baylor University Medical Center, 3410 Worth Street, Suite 860, Dallas, TX 75246, USA. Electronic address: Jacquelo@BaylorHealth.edu.
authors.forename: Jacqueline G
authors.initials: JG
authors.lastname: O'Leary
mesh_terms: D058625:End Stage Liver Disease / Q000503:physiopathology*; D006801:Humans; D008103:Liver Cirrhosis / Q000503:physiopathology; D017114:Liver Failure, Acute / Q000209:etiology / Q000503:physiopathology* / Q000601:surgery; D016031:Liver Transplantation; D008954:Models, Biological; D009102:Multiple Organ Failure / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D012307:Risk Factors
keywords: Acute liver failure; Acute-on-chronic liver failure; Cirrhosis; Liver transplantation; Organ failure